Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Multiple Myeloma 8Lymphoma, Non-Hodgkin 7Leukemia, Myeloid, Acute 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasms, Plasma Cell 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hodgkin Disease 3Glioma 3Primary Myelofibrosis 2Myeloproliferative Disorders 2Melanoma 2Leukemia 2Immunoglobulin Light-chain Amyloidosis 2Glioblastoma 2Wilms Tumor 1Solid Tumor 1Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Neuroblastoma 1Lymphoma, B-Cell 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Fallopian Tube Neoplasms 1

Interventions

Cyclophosphamide 77Dexamethasone 74Melphalan 65Lenalidomide 50Bortezomib 50Peripheral Blood Stem Cell Transplantation 49fludarabine phosphate 47Busulfan 46Filgrastim 39Tacrolimus 37Antilymphocyte Serum 33Radiotherapy 30Mycophenolic Acid 30Thalidomide 28fludarabine 24Methotrexate 22Whole-Body Irradiation 21Cyclosporine 21Calcium Dobesilate 21Granulocyte Colony-Stimulating Factor 18Methylprednisolone 17Etoposide 17Cord Blood Stem Cell Transplantation 14daratumumab 11Prednisone 11Carmustine 11sargramostim 10Stem Cell Transplantation 10Sirolimus 10Rituximab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Plasma Cell × Blood Component Removal × Clear all
NCT01526096 2025-11-05

Stem Cell Transplantation for Patients With Multiple Myeloma

University of Chicago

Phase 1 Completed
30 enrolled
Plasma cell

Neoplasms, Plasma Cell

NCT01174082 2018-06-01

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

M.D. Anderson Cancer Center

Phase 2 Terminated
2 enrolled 7 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00968396 2013-04-05

Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡